RAM Essential Services Property Fund (ASX:REP) outlined steady operating conditions for the first half of FY26, while highlighting progress on its plan to reposition the portfolio toward healthcare assets. Management said occupancy remains in the “high 90s,” leasing spreads were positive, and distributions were maintained, while a proposed divestment of five retail assets is expected […]

Navitas Semiconductor (NASDAQ:NVTS) said it ended 2025 with fourth-quarter revenue at the high end of guidance as the company accelerated its “Navitas 2.0” transformation, a strategic pivot away from its historical mobile and low-end consumer business toward higher-power end markets such as AI data centers and grid infrastructure. Management emphasized that the company’s fourth-quarter results […]

MotorCycle (ASX:MTO) executives highlighted record first-half results for the six months ended 31 December, pointing to strong revenue growth, expanding market share, and an acquisition-led boost from the Peter Stevens and Harley-Davidson transaction completed on 31 July. Chief Executive Officer Matthew Wiesner said the company delivered “record revenue, unit sales, and strong profit growth,” supported […]

Woolworths Group (ASX:WOW) outlined a first-half performance it said reflected deliberate investment to rebuild customer momentum, alongside cost reductions and improving execution, during its FY2026 half-year results call covering the 27 weeks ended January 4, 2026. Group results: sales growth and higher underlying earnings, but significant items weighed on statutory profit Chief Executive Officer Amanda […]

PharmX Technologies (ASX:PHX) reported higher half-year revenue and maintained positive EBITDA in its FY2026 first-half results briefing, while management emphasized early traction from its new “single platform” rollout and outlined the strategic significance of a newly announced alliance with Sigma and Chemist Warehouse. Financial performance: revenue growth and positive EBITDA despite elevated investment CEO Tom […]

Imricor Medical Systems (ASX:IMR) used its full-year FY2025 results call to frame the year as a transition from “proven to ready,” highlighting regulatory milestones in Europe, expanding clinical activity in both Europe and the U.S., and building commercial infrastructure ahead of broader rollouts. Management reiterated the company’s focus on MRI-guided cardiac ablation, aiming to move […]

COSOL (ASX:COS) executives told investors the company’s first-half performance was “deeply unsatisfactory,” citing lower revenue, sharply reduced EBIT, and a pullback from the upward trajectory it had delivered since listing. On the earnings call, management attributed the decline to a combination of contract roll-offs, a contract termination, lower utilization, and a weaker-than-expected sales pipeline. Chief […]

Australian Ethical Investment (ASX:AEF) reported improved earnings and stronger operating leverage for the first half of FY2026, supported by funds under management growth, disciplined cost control, and completion of key operational transitions. Profit growth and dividend increase Group CEO and Managing Director John McMurdo said the business delivered “another very pleasing 6 months of momentum,” […]

Camplify (ASX:CHL) management used its latest earnings call to frame the first half of FY26 as a period of “optimization and stabilization,” emphasizing a shift from integration work in FY25 to tighter execution, margin improvement, and cash generation. Bottom-line improvement and stronger cash position CEO and founder Justin Hales said the company’s focus on expense […]

Freelancer (ASX:FLN) reported a return to profitability in its full-year 2025 results, highlighting record net profit after tax, improving operating cash flow, and stronger contributions from its Escrow.com and Loadshift businesses. Management also emphasized product initiatives centered on AI, trust and safety, and payments infrastructure, while noting a leadership transition with Chief Financial Officer Neil […]

ADMA Biologics (NASDAQ:ADMA) reported fourth-quarter and full-year 2025 results that management said reflected disciplined execution across its commercial, manufacturing, and financial operations, driven primarily by continued growth of its specialty immune globulin product Asceniv. Full-year and fourth-quarter 2025 results For full-year 2025, ADMA reported total revenue of $510.2 million, representing 20% year-over-year growth. The company […]

Heartland Group (ASX:HGH) executives told investors its strategic reset continued to gain traction in the first half of fiscal 2026, driving a sharp recovery in profit, wider margins, and improved credit quality, while the group began multi-year technology programs in both New Zealand and Australia. Group results show profit rebound, margin expansion, and lower impairments […]

Qantas Airways (ASX:QAN) reported higher first-half earnings for FY2026 and announced an interim shareholder distribution, as executives emphasized strong travel demand, improving operational performance, and the accelerating impact of the group’s fleet renewal program. Financial results and shareholder returns Chief Executive Officer Vanessa Hudson said the half was “defined by execution,” with the group focused […]

First Solar (NASDAQ:FSLR) used its fourth-quarter and full-year 2025 earnings call to outline record shipment volumes, an expanding U.S. manufacturing footprint, and a 2026 outlook shaped by ongoing trade, regulatory, and policy uncertainty. Management emphasized that it has remained selective on contracting while prioritizing “contract certainty” in pricing and delivery amid shifting tariffs, pending investigations, […]

Bhagwan Marine (ASX:BWN) reported a “solid performance” for the first half of FY2026, highlighted by improved margins and stronger cash generation despite lower revenue that management attributed largely to the timing of major contract awards. Half-year financial highlights Managing Director and CEO Loui Kannikoski said first-half revenue totaled AUD 116.9 million, down 8.5% from the […]

Lynas Rare Earths (ASX:LYC) used its investor briefing for the half year ended 31 December 2025 to outline progress on its Lynas 2025 capital program, discuss operational ramp-ups in Australia and Malaysia, and highlight a strengthening rare earths price environment that management said is improving market conditions and customer demand. Commissioning milestones and ramp-up progress […]

Paragon Care (ASX:PGC) reported first-half results that management described as a “good solid” underlying performance, while statutory earnings were heavily affected by a board decision to fully provide for an outstanding receivable from the Infinity Group. On an underlying basis, the company posted revenue of AUD 1.9 billion, underlying EBITDA of AUD 49 million, and […]

Ironwood Pharmaceuticals (NASDAQ:IRWD) executives highlighted stronger demand trends for LINZESS, a revamped pricing approach intended to improve 2026 net sales performance, and key next steps for the company’s apraglutide development program during the company’s fourth-quarter and full-year 2025 investor update call. LINZESS demand growth and pediatric IBS-C approval Chief Executive Officer Thomas McCourt said the […]

Smartgroup (ASX:SIQ) executives told investors the company delivered “strong financial results with solid operating momentum” in 2025, supported by higher novated leasing volumes, new client wins, and ongoing investment in its digital platform and operating model. Managing Director and CEO Scott Wharton and CFO Jason King also reiterated a medium-term ambition for EBITDA margin to […]

ARKO (NASDAQ:ARKO) executives said the company’s transformation initiatives drove a stronger finish to 2025, highlighted by higher profitability in the fourth quarter, improved margin performance, and a sharp reduction in retail operating expenses tied to store closures and dealer conversions. On the company’s fourth quarter 2025 earnings call, Chairman, President and CEO Arie Kotler and […]

Interface (NASDAQ:TILE) executives highlighted a “record year” in 2025, citing all-time highs in net sales, adjusted operating income and adjusted EBITDA as the company continued executing its “One Interface” strategy. On the company’s fourth-quarter and full-year 2025 earnings call, CEO Laurel Hurd said results were driven by broad-based regional and segment growth, price and volume […]

Mirum Pharmaceuticals (NASDAQ:MIRM) used its fourth-quarter and full-year 2025 earnings call to outline continued commercial momentum, provide 2026 sales guidance, and preview a busy slate of upcoming clinical catalysts across its cholestatic liver disease franchise and newly added hepatitis delta virus (HDV) program. 2025 sales topped guidance; 2026 outlook calls for continued growth Chief Executive […]

Steven Madden (NASDAQ:SHOO) reported fourth-quarter and full-year 2025 results that management said came in above its guidance for the quarter, supported by improved performance in the core Steve Madden footwear business and a strong contribution from newly acquired Kurt Geiger. Chairman and CEO Ed Rosenfeld described 2025 as a “challenging year,” pointing primarily to disruption […]

Allot (NASDAQ:ALLT) management said the company closed 2025 with accelerated revenue growth, sharply higher cybersecurity recurring revenue and improved profitability, pointing to continued momentum heading into 2026. On the company’s fourth-quarter earnings call, CEO Eyal Harari and CFO Liat Nahum highlighted strong adoption of the firm’s Cybersecurity-as-a-Service (SECaaS) offerings with communications service providers (CSPs) and […]

Secure Energy Services (TSE:SES) executives said the company delivered higher fourth-quarter profitability and modest full-year growth in 2025 despite weaker commodity prices and reduced exploration-related activity, while returning significant capital to shareholders and advancing contracted infrastructure projects. 2025 results and fourth-quarter performance President and CEO Allen Gransch said 2025 “clearly demonstrated the resilience” of the […]

Galapagos (NASDAQ:GLPG) executives used the company’s year-end 2025 financial results call to outline a strategic reset centered on business development, following a decision to wind down its cell therapy activities. Management emphasized that the company ended 2025 with roughly €3 billion in cash, which it views as a key source of flexibility as it searches […]

ExlService (NASDAQ:EXLS) executives highlighted accelerating client adoption of data and AI initiatives as the company reported fourth-quarter and full-year 2025 results that management said exceeded expectations for both revenue and earnings per share. The company also provided 2026 guidance calling for continued organic growth and adjusted earnings expansion, while noting the expected impact of India’s […]

Immunocore (NASDAQ:IMCR) executives highlighted continued commercial momentum for KIMMTRAK and progress across a diversified pipeline during the company’s fourth-quarter and full-year 2025 earnings call. Management emphasized that 2025 results reflected “consistent execution” and pointed investors to multiple upcoming clinical milestones, including three ongoing phase III trials in melanoma and expanding efforts in infectious disease and […]

Leonardo DRS (NASDAQ:DRS) executives highlighted strong organic growth, record bookings, and rising investment in capacity and research during the company’s fourth-quarter and full-year 2025 earnings call. The discussion also included management updates, a new license agreement tied to quantum computing, and the conclusion of a legacy international program that resulted in an unexpected loss. Leadership […]

Tyro Payments (ASX:TYR) used its FY2026 half-year earnings call to highlight improving payment volume trends, stronger profitability and cash generation, and increased investment plans for the second half as it pushes into new growth initiatives and integrates its recently announced acquisition of Thriday. New CEO outlines focus and Thriday rationale Chief Executive Officer Nigel Lee, […]

Glanbia (LON:GLB) reported a “robust” full-year 2025 performance, led by like-for-like revenue and volume growth across all three segments, but faced a significant profitability headwind from record whey input costs in its Performance Nutrition business. Chief Executive Officer Hugh McGuire said the group saw strong consumer demand for its better nutrition brands and ingredients, while […]

BWX Technologies (NYSE:BWXT) executives said the company finished “a record 2025” with fourth-quarter results that exceeded internal expectations, citing strong demand across nuclear end markets, expanding backlog, and momentum in commercial nuclear power and medical isotopes. 2025 performance and backlog growth CEO Rex Geveden said full-year 2025 revenue grew 18% while adjusted EBITDA increased 15%. […]

Forward Air (NASDAQ:FWRD) executives highlighted steady consolidated results, improving earnings quality, and progress on a strategic alternatives review during the company’s fourth-quarter and full-year 2025 earnings call. Management also pointed to ongoing transformation initiatives, technology modernization efforts, and signs that freight markets may be nearing an inflection point, while emphasizing that clear evidence of a […]

Marqeta (NASDAQ:MQ) reported fourth-quarter 2025 results marked by accelerating processing volume growth, record adjusted EBITDA, and a path toward GAAP profitability, while outlining a 2026 outlook shaped by contract renewals, Block pricing tier changes, and assumptions tied to Cash App issuance diversification. Fourth-quarter results show record TPV and profitability gains CEO Mike Milotich said the […]

Inogen (NASDAQ:INGN) executives highlighted improving profitability, international momentum, and a broadened product portfolio during the company’s fourth-quarter 2025 earnings call held February 24, 2026. Management also introduced 2026 revenue guidance and disclosed a new $30 million share repurchase authorization to be executed across 2026 and 2027. Revenue growth led by international; U.S. sales pressured by […]

Cytokinetics (NASDAQ:CYTK) used its fourth-quarter 2025 earnings call to highlight a major transition for the company: the approval and initial U.S. launch execution of MYQORZO for adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM), alongside advancing late-stage clinical programs and providing 2026 expense guidance. MYQORZO approvals mark shift to commercial-stage company President and CEO Robert Blum […]

Stealth Group (ASX:SGI) used its half-year FY2026 investor presentation to highlight what management called a record first-half result, alongside an updated strategic roadmap following the November 2025 acquisition of Hardware & Building Traders (HBT). Management emphasized that the company has now delivered “12 consecutive periods of growth” across profit and loss metrics and believes it […]

Steadfast Group (ASX:SDF) used its FY26 half-year results call to highlight profit growth, an active acquisition program, and a renewed focus on cost discipline as insurance pricing moderates from recent highs. Management also reiterated full-year guidance and emphasized ongoing investments in technology and AI to streamline workflows and support broker productivity. First-half earnings: higher NPAT […]

WiseTech Global (ASX:WTC) reported first-half FY26 results that management said were in line with internal expectations, alongside a significant expansion of its AI-led operating model, continued rollout of its transaction-based commercial model, and further progress integrating E2open. First-half results and dividend CEO Zubin Appoo said reported revenue grew 76% year over year, with reported EBITDA […]

Service Stream (ASX:SSM) management said the company delivered a strong first-half performance for FY 2026, highlighting margin expansion, robust cash conversion, and record contract wins as it continues to execute its strategy focused on growth, diversification, and improving the quality of earnings. First-half highlights: margin lift, strong cash flow, higher dividend Managing Director Leigh Mackender […]

Fleetwood (ASX:FWD) used its FY26 first-half results call to highlight higher earnings, a capital management reset anchored by a fully franked interim dividend and a new buyback, and a sharply improved outlook for its Community Solutions business as occupancy at its Searipple accommodation village surged. Chairman John Klepec introduced new CEO Andrea Pidcock, who said […]

Big River Industries (ASX:BRI) management told investors its first-half FY26 result reflected resilient margins, strong cash conversion and ongoing cost discipline despite continued softness in parts of the residential construction market. CEO and Managing Director John Lorente, joined by CFO John O’Connor, said the group’s revenue decline moderated versus recent periods and pointed to early […]

Growthpoint Properties Australia (ASX:GOZ) executives used the company’s half-year FY2026 results presentation to highlight strong leasing momentum, a stable portfolio backdrop and progress in its funds management growth strategy, while also acknowledging the impact of upcoming lease expiries on second-half earnings. Half-year earnings and updated guidance Chief Executive Officer and Managing Director Ross Lees said […]

Fortescue (ASX:FMG) executives said the miner delivered record first-half shipments, maintained an industry-leading cost position, and increased cash generation, while accelerating a multi-year decarbonization program aimed at lowering structural operating costs and supporting longer-term growth options in metals and energy. Record shipments, low costs, and shareholder returns In opening remarks, Growth and Energy CEO Dino […]

Accent Group (ASX:AX1) outlined half-year results for the period ended December 28, 2025 and provided an eight-week trading update for the start of the second half of FY26, describing a “promotional trading environment” but noting growth across multiple parts of the portfolio. H1 FY26 sales growth and portfolio changes Management said total sales for the […]

Astronics (NASDAQ:ATRO) capped fiscal 2025 with what management described as a “very strong” fourth quarter, posting record revenue and improved profitability as higher sales volume, favorable mix, and pricing and productivity initiatives combined to lift margins. Executives also reiterated preliminary fiscal 2026 revenue guidance and discussed order trends, tariffs, and key program catalysts during the […]

Kelsian Group (ASX:KLS) reported a record first-half result for the six months ended 31 December 2025 and upgraded its full-year earnings guidance, citing revenue indexation in contracted operations, growth in U.S. employee shuttle contracts, and improved performance across marine and tourism. Record first-half results and margin expansion Group CEO Graeme Legh said the record outcome […]

Paymentus (NYSE:PAY) management highlighted record revenue, expanding profitability, and strong backlog as the company reported fourth-quarter and full-year 2025 results that exceeded its expectations and topped the high end of its guidance ranges across key metrics. 2025 milestones and strategy commentary Founder and CEO Dushyant Sharma described 2025 as a “significant milestone year,” noting that […]

Tasmea (ASX:TEA) executives told investors the company delivered a strong first-half result and reiterated full-year earnings guidance, citing continued organic growth, early benefits from acquisitions, and a highly visible second-half workload supported by long-term customer agreements and a growing order book. Half-year performance and guidance reaffirmed Managing Director Stephen Young said underlying EBIT for the […]

Generation Development Group (ASX:GDG) detailed a strong first-half performance for FY26, citing broad-based growth across its Generation Life, Evidentia managed accounts, and Lonsec research businesses, alongside continued investment in staff, technology, and product development. Management also highlighted legislative and regulatory tailwinds, progress on its BlackRock alliance, and a measured rollout of artificial intelligence initiatives aimed […]